Searched over 200M research papers
8 papers analyzed
These studies suggest A1C stands for hemoglobin A1c or glycated hemoglobin A1C.
19 papers analyzed
A1C stands for hemoglobin A1C, which is a form of hemoglobin that is chemically linked to glucose. This linkage occurs through a process called glycation, where glucose molecules attach to hemoglobin in the blood .
Hemoglobin A1C is a critical marker used in the diagnosis and management of diabetes mellitus. It measures the average blood glucose levels over the past two to three months, providing a long-term indicator of blood sugar control . This is particularly useful for both diagnosing diabetes and monitoring the effectiveness of treatment plans.
While A1C is a valuable tool, it is not without limitations. Various conditions can affect its accuracy, such as those impairing erythrocyte production or altering the glycation process. Factors like patient ethnicity and aging can also introduce variability in A1C readings. Therefore, understanding these limitations is crucial for clinicians to make informed decisions.
With the advent of continuous glucose monitoring (CGM), there is a growing interest in understanding how CGM metrics correlate with A1C. The estimated A1C (eA1C) converts mean glucose readings from CGM into an A1C estimate. However, discrepancies between eA1C and laboratory-measured A1C can cause confusion among patients and clinicians.
To address these discrepancies, the term "Glucose Management Indicator" (GMI) has been introduced. GMI provides a more accurate estimate of A1C based on CGM data, helping to bridge the gap between continuous glucose monitoring and traditional A1C measurements.
Research has established a mathematical relationship between A1C levels and average glucose (AG) levels. This relationship allows A1C to be expressed as estimated average glucose (eAG), making it easier for patients to understand their blood sugar levels in the same units used for daily monitoring. This conversion is particularly useful for day-to-day diabetes management.
Hemoglobin A1C (HbA1C) is a vital marker in diabetes care, providing insights into long-term blood glucose control. Despite its limitations, it remains a cornerstone in both diagnosis and management. Advances like the Glucose Management Indicator (GMI) and the translation of A1C into estimated average glucose (eAG) are enhancing its utility, making diabetes management more precise and patient-friendly.
Most relevant research papers on this topic